Author | Charles Erlichman, MD

Articles

Irinotecan Plus 5-FU and Leucovorin in Advanced Colorectal Cancer: North American Trials

August 06, 1998

Both fluorouracil (5-FU) and irinotecan (CPT-11 [Camptosar]) have shown activity in metastatic colorectal cancer and are approved for its treatment in the United States. Preclinical experiments in cell cultures and human tumor